DOI : 10.1055/s-00000020

Geburtshilfe und Frauenheilkunde

Issue 11 · Volume 78 · November 2018 DOI: 10.1055/s-008-41819

Kommission für Translationale Forschung der Arbeitsgemeinschaft für Gynäkologische Onkologie AGO e.V.
Abstracts of the 10th Scientific Symposium of the Comission for Translational Research of the Working group for Gynecologic Oncology AGO e.V.
Düsseldorf, 07.–08.09.2018

Sprecher AGO-TraFo: Peter A. Fasching

01
Stepputtis, SS; Metzger, E; Strietz, J; Stickeler, E; Schüle, R; Maurer, J: KDM 4 Inhibition Targets Breast Cancer Stem-like Cells
05
Kommoss, S; Heitz, F; Winterhoff, BJN; Wang, C; Sehouli, J; Aliferis, C; Kimmig, R; Wang, J; Ma, S; de Gregorio, N; Mahner, S; du Bois, A; Tourani, R; Park-Simon, TW; Baumann, K; Taran, FA; Kommoss, F; Schroeder, W; Dowdy, SC; Pfisterer, J: Significant Overall Survival Improvement In Proliferative Subtype Ovarian Cancer Patients Receiving Bevacizumab
06
Banys-Paluchowski, M; Milde-Langosch, K; Fehm, T; Witzel, I; Oliveira-Ferrer, L; Schmalfeldt, B; Müller, V: Clinical relevance of H-RAS, K-RAS and N-RAS in a large cohort of primary breast cancer patients
08
Hedemann, N; Yousry Youssef Yanni, C; Rogmans, C; Tribian, N; Sebens, S; Wesch, D; Schmidt-Arras, D; Weimer, J; Arnold, N; Maass, N; Bauerschlag, DO: A Disintegrin and Metalloprotease 17 (ADAM17) and its downstream signaling in chemotherapeutic resistance of ovarian cancer
09
Feuerborn, J; Yousry Youssef Yanni, C; Rogmans, C; Treeck, L; Arnold, N; Maass, N; Bauerschlag, DO; Hedemann, N: Funktion des Nectin-4 bei der Entstehung von Resistenzmechanismen im Ovarialkarzinom und die Validierung als potenziell prädiktiver und prognostischer Marker
10
Müller, C; Juhasz-Böss, S; Schmidt, G; Gabriel, L; Hayo, C; Radosa, J; Solomayer, EF; Breitbach, GP; Juhasz-Böss, I: Einflussfaktoren auf den Beginn einer neoadjuvanten Chemotherapie bei Mammakarzinom
15
Honisch, E; Fröhlich, RL; Vesper, AS; Beyer, I; Rudelius, M; Köhrer, K; Scheuring, S; Fehm, T; Niederacher, D: Identifizierung von Mutationsprofilen hereditärer BRCA1-assoziierter TNBCs
20
Weimer, J; Nusilati, A; Tiemann, K; Stope, MB; Mustea, A; Karow, D; Hamann, S; Hedemann, N; Flörkemeier, I; Röcken, C; Bauerschlag, D; Arnold, N; Maass, N: Array based Copy number variations (aCNV) are able to differ classes in endometrial carcinoma
21
Nusilati, A; Weimer, J; Tiemann, K; Stope, MB; Mustea, A; Karow, D; Hamann, S; Hedemann, N; Flörkemeier, I; Röcken, C; Bauerschlag, D; Arnold, N; Maass, N: Imbalances and loss of heterozygosity (LOH) in endometrial carcinoma detected by array based Copy number variations (aCNV)
22
Esser, K; Kulik, A; Klinger, A; Fleischer, E; Neubauer, H; Niederacher, D; Fehm, T: Lead structure optimization of compounds identified to induce differentiation in solid tumors
25
Banys-Paluchowski, M; Fehm, T; Witzel, I; Aktas, B; Fasching, PA; Hartkopf, A; Janni, W; Kasimir-Bauer, S; Pantel, K; Schön, G; Rack, B; Riethdorf, S; Solomayer, EF; Müller, V: The prognostic relevance of urokinase-type plasminogen activator (uPA) in the blood of patients with metastatic breast cancer
27
Kasoha, M; Takacs, Z; Radosa, J; Bohle, R; Schmidt, G; Linxweiler, M; Schick, B; Juhasz-Böss, I; Solomayer, EF: Protein expression of SEC62 in triple-negative breast cancer
28
Blum, S; Häberle, L; Tchartchian, G; Schippert, C; Fehm, T; Hartung, CP; Widschwendter, P; Reicke, S; Füger, T; Germeyer, A; Oppelt, P; Lange, J; Fleisch, M; Renner, SP; Hein, A; Fasching, PA; Beckmann, MW; Burghaus, S: Cancers in Patients with Endometriosis
29
Kasoha, M; Radosa, J; Solomayer, EF; Juhasz-Böss, I; Bohle, RM; Schmidt, G: Identifikation von Prognosefaktoren beim triple-negativen Mammakarzinom
30
Huebner, H; Erber, R; Hein, A; Lux, MP; Jud, S; Kremer, AN; Kranich, H; Mackensen, A; Häberle, L; Hack, C; Rauh, C; Wunderle, M; Gaß, P; Rabizadeh, S; Brandl, AL; Langemann, H; Volz, B; Nabieva, N; Schulz-Wendtland, R; Dudziak, D; Beckmann, MW; Hartmann, A; Fasching, PA; Rübner, M: TILGen: A Program to Investigate Immune Targets in Breast Cancer Patients – First Results on the Influence of Tumor-Infiltrating Lymphocytes